[
  {
    "ts": "2025-11-24T12:56:23+00:00",
    "headline": "What Makes Charles River Laboratories (CRL) an Investment Bet?",
    "summary": "Madison Investments, an investment advisor, released its “Madison Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The third quarter was difficult for the Small Cap Fund. The small-cap index’s performance was broad-based. The Madison Small Cap Fund (class Y) was down 1.3% in the quarter, significantly underperforming the […]",
    "url": "https://finance.yahoo.com/news/makes-charles-river-laboratories-crl-125623619.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "6eb1af32-613d-3781-88d0-ac4cc657812e",
      "content": {
        "id": "6eb1af32-613d-3781-88d0-ac4cc657812e",
        "contentType": "STORY",
        "title": "What Makes Charles River Laboratories (CRL) an Investment Bet?",
        "description": "",
        "summary": "Madison Investments, an investment advisor, released its “Madison Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The third quarter was difficult for the Small Cap Fund. The small-cap index’s performance was broad-based. The Madison Small Cap Fund (class Y) was down 1.3% in the quarter, significantly underperforming the […]",
        "pubDate": "2025-11-24T12:56:23Z",
        "displayTime": "2025-11-24T12:56:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/0e857ae9b0144d1996b14fb908ea3840",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/brh3fJuygdiS8j7qgVO3lQ--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/0e857ae9b0144d1996b14fb908ea3840.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FkjVFWm.A9_NXt5p9KTolg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/0e857ae9b0144d1996b14fb908ea3840.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/makes-charles-river-laboratories-crl-125623619.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/makes-charles-river-laboratories-crl-125623619.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]